FTNT

Fortinet, Inc.

Fundamental data last updated:July 9, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Technology

industry

Software - Infrastructure

Exchange

NASDAQ

County of HQ

US

Next Earnings Date

07/29/2026

Business Summary

Fortinet, Inc. specializes in delivering extensive, unified, and automated cybersecurity solutions to a global clientele, encompassing the Americas, Europe, the Middle East, Africa, and the Asia Pacific regions. At its core, the company offers FortiGate, a powerful platform combining hardware and software licenses that provides a comprehensive suite of security and networking functionalities. This includes firewall capabilities, intrusion prevention, anti-malware defense, virtual private network (VPN) services, application control, web filtering, anti-spam measures, and wide area network (WAN) acceleration. Beyond its flagship product, Fortinet provides a diverse portfolio of specialized security tools. These range from FortiSwitch for secure network switching and FortiAP for robust wireless connectivity, to FortiExtender, a versatile hardware appliance. For centralized network visibility and control, clients utilize FortiAnalyzer for logging, analysis, and reporting, and FortiManager for scalable administration of FortiGate devices. The company further fortifies digital defenses with FortiWeb (web application firewalls), FortiMail (secure email gateways), and FortiSandbox technology, which offers proactive threat detection and mitigation. Endpoint protection is a key focus, delivered through FortiClient (featuring pattern-based anti-malware, behavior-based exploit protection, web-filtering, and an application firewall) and the advanced FortiEDR/XDR suite, which leverages machine learning for anti-malware execution and real-time post-infection defense. Additionally, FortiToken and FortiAuthenticator product families provide essential multi-factor authentication to safeguard systems and data. Fortinet's service offerings include security subscriptions, technical support, professional consulting, and training programs. Its robust security technologies are distributed both directly to end-users and through an extensive network of channel partners. The company serves a wide array of sectors, including telecommunications, technology, government, financial services, education, retail, manufacturing, and healthcare. Headquartered in Sunnyvale, California, Fortinet, Inc. was established in 2000 and maintains a strategic alliance with Linksys.

 


VALUATION

P/E

59.24

Market Cap ($M USD)

$114.81B

Forward P/E

47.47

PEG

1.91

PRICE TO SALES

16.15

PRICE TO BOOK

116.98

EV / EBITDA

42.06

5-Year Average P/E

Free Cash Flow Yield

2.12%

DCF Value

$79.27

Graham Number

$8.93

Price to FCF

47.14

EV to FCF

46.43

Earnings Yield

1.69%

FCF Yield

2.12%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$2.65

Next Year EPS Growth Estimate

$3.30

Next Year Revenue Growth Estimate

$1.20T

Return on Equity (ROE)

155.65%

FREE CASH FLOW

Operating Margin

31.06%

Debt-to-Equity

0.81

Piotroski F-Score

6

Altman Z-Score

9.53

Return on Invested Capital (ROIC)

41.98%

Current Ratio

1.15

Quick Ratio

1.07

Net Debt to EBITDA

-0.64

Interest Coverage

113.82

Gross Profit margin

80.67%

FCF PER SHARE

$3.30

REVENUE PER SHARE

$9.62

Gainseekers Quantitative Analysis

Summary

Sanofi’s valuation presents a compelling case of market mispricing. With a DCF value significantly higher than its snapshot price, the stock appears undervalued. The Forward P/E of 7.25 suggests a cautious market outlook, yet the earnings yield of 11.75% indicates robust profitability. However, the Altman Z-score of 1.58 raises concerns about financial distress risk. Overall, the market seems to be underestimating Sanofi’s intrinsic value and growth potential.

AI Exposure / Tech Reliance

In the healthcare sector, Sanofi is well-positioned to leverage AI and tech advancements. The drug manufacturing industry is increasingly integrating AI for drug discovery and personalized medicine. Sanofi's ability to adapt to these shifts could enhance its competitive edge.

The Bull Case

For value and GARP investors, Sanofi offers a tantalizing opportunity. The ROIC of 15.07% and a strong FCF yield of 21.46% underscore its capital efficiency and cash generation prowess. A Piotroski F-Score of 6 indicates solid financial health, while an operating margin of 25.09% showcases its pricing power. These metrics paint a picture of a company with robust fundamentals and efficient management.

The Bear Case

Despite its strengths, Sanofi faces notable risks. The Altman Z-score suggests potential financial instability, and the quick ratio of 0.22 indicates liquidity concerns. Trading below its 50-day and 200-day SMAs, the stock may be technically oversold, but this also reflects market skepticism. Additionally, the forward EPS estimate shows a decline, hinting at potential earnings pressure.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Hold

Average Analyst Price Target

$99.52

Institutional Ownership %

1-Year Beta

1.09

Insider Buying % (6 Mo)

Distance to 52-Week High

4.38%

Distance to 52-Week Low

55.25%

EARNINGS SURPRISE %

32.47%

50-DAY SMA

$129.83

200-DAY SMA

$93.96

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.